ReNAgade Therapeutics’ $300 Million Series A Financing Round

Goodwin advised ReNAgade Therapeutics on the fundraising.ReNAgade Therapeutics announced a $300 million Series A financing round led by MPM BioImpact and F2 Ventures. ReNAgade has built…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now